Method and apparatus for controlling an extra-corporeal blood treatment in a medical device

US9162020B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9162020-B2
Application numberUS-201113175131-A
CountryUS
Kind codeB2
Filing dateJul 1, 2011
Priority dateJul 8, 2010
Publication dateOct 20, 2015
Grant dateOct 20, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Apparatus for controlling an extra-corporeal blood treatment in a medical device, comprising a blood treatment device ( 7 ), an extra-corporeal blood transport line ( 4 ), a fluid transport line ( 3 ) for a treatment fluid for the blood, at least a sensor adapted to provide a measure (M) correlated to at least a treatment parameter of the extra-corporeal blood treatment and/or of the treatment device ( 7 ) in the medical device ( 1 ), at least one storage memory ( 29 ), and at least a control device ( 28 ), operatively connected at least with the storage memory ( 29 ) and with the sensor, and configured for receiving the measure (M) from the sensor, correlating the measure (M) with referential data (R) of the treatment device for the treatment parameter provided by the at least one storage memory ( 29 ), and correlating the measure (M) with patient historical data (H) for the treatment parameter for obtaining an information representative of the quality of the extra-corporeal blood treatment.

First claim

Opening claim text (preview).

The invention claimed is: 1. Apparatus for controlling an extra-corporeal blood treatment in a medical device, comprising: a blood treatment device, the blood treatment device being a dialyzer; an extra-corporeal blood transport line, having at least an arterial line configured to bring blood from a first access of a patient under treatment to said blood treatment device, a venous line configured to bring blood from said blood treatment device to a second access of the patient,…

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9162020B2 cover?
Apparatus for controlling an extra-corporeal blood treatment in a medical device, comprising a blood treatment device ( 7 ), an extra-corporeal blood transport line ( 4 ), a fluid transport line ( 3 ) for a treatment fluid for the blood, at least a sensor adapted to provide a measure (M) correlated to at least a treatment parameter of the extra-corporeal blood treatment and/or of the treatment …
Who is the assignee on this patent?
Vantard Georges, Bene Bernard, Gambro Lundia Ab
What technology area does this patent fall under?
Primary CPC classification A61M1/16. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).